Functional and quality-of-life outcomes of transoral robotic surgery for carcinoma of unknown primary

Laryngoscope

Volumn 124, Issue 9, 2014, Pages 2089-2095

  Durmus, Kasim ^a   Patwa, Hafiz S ^a   Gokozan, Hamza N ^a   Kucur, Cuneyt ^a   Teknos, Theodoros N ^a   Agrawal, Amit ^a   Old, Matthew O ^a   Ozer, Enver ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

carcinoma of unknown primary; neck metastasis; quality of life; Transoral robotic surgery; transoral robotic surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BASE OF TONGUE; CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; DEMOGRAPHY; EATING; ESTHETICS; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MALE; MINIMALLY INVASIVE PROCEDURE; PALATINE TONSIL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SOCIAL ASPECT; SOCIAL DISRUPTION; SPEECH; TONGUE; TRANSORAL ROBOTIC SURGERY; WART VIRUS;

CARCINOMA OF UNKNOWN PRIMARY; NECK METASTASIS; QUALITY OF LIFE; TRANSORAL ROBOTIC SURGERY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH; NEOPLASMS, UNKNOWN PRIMARY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECOVERY OF FUNCTION; ROBOTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906716649     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24705     Document Type: Article

References (22)

1. Nieder C, Ang KK,. Cervical lymph node metastases from occult squamous cell carcinoma. Curr Treat Options Oncol 2002; 3: 33-40.
2. Karni RJ, Rich JT, Sinha P, Haughey BH,. Transoral laser microsurgery: a new approach for unknown primaries of the head and neck. Laryngoscope 2011; 121: 1194-1201.
3. Strojan P, Ferlito A, Medina JE, et al. Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck 2013; 35: 123-132.
4. Strojan P, Ferlito A, Langendijk JA, et al. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck 2013; 35: 286-293.
5. Cianchetti M, Mancuso AA, Amdur RJ, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009; 119: 2348-2354.
6. Waltonen JD, Ozer E, Hall NC, Schuller DE, Agrawal A,. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg 2009; 135: 1024-1029.
7. Balaker AE, Abemayor E, Elashoff D, St John MA,. Cancer of unknown primary: does treatment modality make a difference? Laryngoscope 2012; 122: 1279-1282.
8. Nieder C, Gregoire V, Ang KK,. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 2001; 50: 727-733.
9. Chen AM, Li BQ, Farwell DG, Marsano J, Vijayakumar S, Purdy JA,. Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin. Int J Radiat Oncol Biol Phys 2011; 79: 756-762.
10. Abuzeid WM, Bradford CR, Divi V,. Transoral robotic biopsy of the tongue base: A novel paradigm in the evaluation of unknown primary tumors of the head and neck. Head Neck 2013; 35: E126-E130.
11. Mehta V, Johnson P, Tassler A, et al. A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery. Laryngoscope 2013; 123: 146-151.
12. Hurtuk A, Agrawal A, Old M, Teknos TN, Ozer E,. Outcomes of transoral robotic surgery: a preliminary clinical experience. Otolaryngol Head Neck Surg 2011; 145: 248-253.
13. Funk GF, Karnell LH, Christensen AJ, Moran PJ, Ricks J,. Comprehensive head and neck oncology health status assessment. Head Neck 2003; 25: 561-575.
14. Funk GF, Karnell LH, Smith RB, Christensen AJ,. Clinical significance of health status assessment measures in head and neck cancer: what do quality-of-life scores mean? Arch Otolaryngol Head Neck Surg 2004; 130: 825-829.
15. Hurtuk AM, Marcinow A, Agrawal A, Old M, Teknos TN, Ozer E,. Quality-of-life outcomes in transoral robotic surgery. Otolaryngol Head Neck Surg 2012; 146: 68-73.
16. Dziegielewski PT, Teknos TN, Durmus K, et al. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. JAMA Otolaryngol Head Neck Surg 2013; 139: 1099-1108.
17. Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS,. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2011; 137: 1112-1116.
18. Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007; 85: 64-73.
19. Logemann JA, Pauloski BR, Rademaker AW, et al. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 2008; 30: 148-158.
20. Leonhardt FD, Quon H, Abrahao M, O'Malley BW Jr, Weinstein GS,. Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck 2012; 34: 146-154.
21. Genden EM, Kotz T, Tong CC, et al. Transoral robotic resection and reconstruction for head and neck cancer. Laryngoscope 2011; 121: 1668-1674.
22. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology. Head and neck cancers. Version 2.2013. May 29, 2013. Available at: http://www.nccn.org/professionals/physician-gls/pdf/head-and-neck.pdf. Accessed February 11, 2014.